Tsuyoshi Hata
Papers
3
Total Citations
24
H-Index
3
About
Dr. Tsuyoshi Hata is a leading surgical oncologist whose research is reshaping the treatment landscape for rectal cancer, with a particular focus on optimizing patient outcomes through innovative neoadjuvant therapies and advanced surgical technologies. His work spans three critical areas: total neoadjuvant therapy (TNT) combined with immunotherapy, the prediction and management of low anterior resection syndrome (LARS), and the application of mixed reality in robotic surgery. Dr. Hata’s most cited paper (11 citations) reports a landmark case of locally advanced rectal cancer (LARC) treated with TNT plus nivolumab, suggesting a promising path toward non-operative management. He also developed and validated the first Japanese predictive model for LARS (7 citations), a tool that enables personalized postoperative care by identifying patients at high risk for bowel dysfunction. Demonstrating his commitment to surgical precision, Dr. Hata has pioneered the use of 3D mixed reality models during robotic rectal cancer surgery (6 citations), overlaying patient-specific anatomy onto the operative field to enhance dissection accuracy. With a growing citation impact, Dr. Hata is at the forefront of integrating immunotherapy, predictive analytics, and augmented reality to advance the standard of care for rectal cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3